4A01.22ICD-11 MMS 2026-01
Immune dysregulation syndromes presenting primarily with lymphoproliferation
Index terms
- Immune dysregulation syndromes presenting primarily with lymphoproliferation
- Autosomal recessive lymphoproliferative disease
- Autoimmune lymphoproliferative syndrome
Show allHide
- Canale-Smith syndrome
- FAS deficiency
- FAS deficiency (ALPS-FAS)(ALPS1a)
- autoimmune lymphoproliferative syndrome with recurrent infections
- Caspase 8 defect (ALPS2b)
- ALPS-NRAS
- ALPS-KRAS
- ALPS-FASLG (ALPS1b)
- ALPS-CASP10 (ALPS2a)
- X-linked lymphoproliferative disease
- Immunodeficiency following hereditary defective response to Epstein-Barr virus
- Purtilo syndrome
- XLPS - [x-linked lymphoproliferative syndrome]
- immunodeficient hereditary defective response to Epstein Barr virus
- x-linked lymphoproliferation disease
- x-linked lymphoproliferative disease or disorder
- x-linked lymphoproliferative syndrome
- Fatal Epstein Barr virus syndrome
- XIAP deficiency (XLP2)
- SH2D1A deficiency (XLP1)
Exclusions from above levels
Sibling codes
4A01.20– Immune dysregulation syndromes with hypopigmentation4A01.21– Immune dysregulation syndromes presenting primarily with autoimmunity4A01.23– Primary haemophagocytic lymphohistiocytosis4A01.2Y– Other specified diseases of immune dysregulation4A01.2Z– Diseases of immune dysregulation, unspecified
Foundation entity
Immune dysregulation syndromes presenting primarily with lymphoproliferation – http://id.who.int/icd/entity/969875874
Part of: 4A01.2: Diseases of immune dysregulation › 4A01: Primary immunodeficiencies due to disorders of adaptive immunity › 04: Diseases of the immune system